BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/9/2021 9:07:56 AM | Browse: 985 | Download: 2606
Publication Name World Journal of Gastroenterology
Manuscript ID 62307
Country China
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Observational Study
Article Title Exploration of nucleos(t)ide analogues cessation in chronic hepatitis B patients with hepatitis B e antigen loss
Manuscript Source Unsolicited Manuscript
All Author List Yan Xue, Meng Zhang, Tao Li, Feng Liu, Li-Xin Zhang, Xiao-Ping Fan, Bao-Hua Yang and Lei Wang
ORCID
Author(s) ORCID Number
Yan Xue http://orcid.org/0000-0001-6185-2424
Meng Zhang http://orcid.org/0000-0002-9336-9776
Tao Li http://orcid.org/0000-0002-2548-5476
Feng Liu http://orcid.org/0000-0001-7060-3710
Li-Xin Zhang http://orcid.org/0000-0001-9795-6487
Xiao-Ping Fan http://orcid.org/0000-0002-8818-4064
Bao-Hua Yang http://orcid.org/0000-0002-4702-7492
Lei Wang http://orcid.org/0000-0002-8240-9795
Funding Agency and Grant Number
Funding Agency Grant Number
Shandong Province Natural Science Foundation ZR2019PH052
National Key Research and Development Program of China 2017YFC0908104
Corresponding Author Lei Wang, MD, Professor, Department of Infectious Diseases and Hepatology, The Second Hospital, Cheeloo College of Medicine, Shandong University, No. 247 Beiyuan Road, Jinan 250033, Shandong Province, China. wlsdeygbk@163.com
Key Words Chronic hepatitis B; Hepatitis B e antigen; Nucleos(t)ide analogues; Cessation
Core Tip A considerable proportion of patients fail to achieve hepatitis B e antigen (HBeAg) seroconversion after the long-term loss of HBeAg, even if hepatitis B surface antigen loss occurs. It remains unclear whether nucleos(t)ide analogs (NAs) can be discontinued in this subset of patients. The current study included patients who discontinued NAs after achieving HBeAg loss (without hepatitis B e antibody) for long periods since 2001. We concluded that these patients may be able to discontinue NAs therapy after long-term consolidation. HBsAg at cessation < 100 IU/mL predicts sustained virological response after NAs cessation. Careful monitoring, especially in the early stages after cessation, may ensure a favorable outcome.
Publish Date 2021-04-09 09:07
Citation Xue Y, Zhang M, Li T, Liu F, Zhang LX, Fan XP, Yang BH, Wang L. Exploration of nucleos(t)ide analogues cessation in chronic hepatitis B patients with hepatitis B e antigen loss. World J Gastroenterol 2021; 27(14): 1497-1506
URL https://www.wjgnet.com/1007-9327/full/v27/i14/1497.htm
DOI https://dx.doi.org/10.3748/wjg.v27.i14.1497
Full Article (PDF) WJG-27-1497.pdf
Full Article (Word) WJG-27-1497.docx